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Abstract 
Purpose: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral disease with high mortality. The agent causing 
CCHF is a Nairovirus. The virus is typically transmitted to humans through tick bites. CCHF is a life-threatening disease 
observed endemically over a wide geographical regions in the world and a little known about pulmonary findings in 
CCHF patients.
Methods: The patients that were admitted and diagnosed with CCHF between April 2010 and September 2015 
were examined. Patients’ medical records were then evaluated retrospectively. Patients who underwent thorax CT 
evaluation based on the clinical findings at the time of admission and/or during the hospital stay were included in 
the study. Patients’ laboratory test results and thorax CT findings for respiratory assessment along with demographic 
characteristics.
Results: Forty patients diagnosed with CCHF that underwent thorax CT based on their indications were included 
in the study. Twenty-seven patients (62.5 %) were male with a mean age of 55.22 ± 19.84 years. According to these 
results, the three most common thorax CT findings were parenchymal infiltration [32 patients (80 %)], pleural effusion 
[31 patients (77.5 %)], and alveolar infiltration [28 patients (70 %)]. Moreover, we determined that the most frequently 
seen radiological findings often occurred bilaterally.
Conclusions: There is still not enough information regarding this life-threatening disease. We also would like to 
emphasize that both direct radiography and thorax CT are highly successful in detecting frequently encountered 
radiological findings such as pleural effusion, alveolar hemorrhage, and parenchymal infiltration that indicate pulmo-
nary involvement.
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Background
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic 
viral disease with a high mortality. CCHF is caused by 
Nairovirus, which is an RNA-type virus from the Bunya-
viridae family. It is generally transmitted through the bite 
of vectors, such as ticks. Although rare, infection with 
CCHF has also been reported in health care profession-
als as a result of contact with blood and blood products. 
Non-specific symptoms such as fever, malaise, loss of 
appetite, nausea, vomiting, and myalgia might occur after 
contact with infected blood. In addition to these non-
specific symptoms, bruising, petechiae, vaginal bleeding, 
and epistaxis as well as signs of intracranial, gastrointes-
tinal, and alveolar hemorrhage that may be life threaten-
ing and often responsible for mortality might occur. The 
mortality rate due to CCHF ranges from 3 to 80 %. The 
disease was named Crimean-Congo hemorrhagic fever 
after the first case of the disease was seen in Crimea in 
1944 and a similar case was reported in Congo 12 years 
later. Furthermore, it is endemic in many parts of the 
world. In literature, the CCHF cases from about 30 coun-
tries encompassing Africa, Asia, Eastern Europe, and 
the Middle East have been reported, with the number of 
cases increasing each year (Karti 2009; Ergönül 2006).
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Despite the increasing number of cases in Turkey and 
other endemic areas in the world over the years, the 
number of studies related to CCHF’s lung findings is 
very limited. In particular, very little is known about the 
effects of extensive, systemic inflammation and vascular 
damage symptoms on pathophysiological changes in the 
lung tissue as well as its clinical outcome. Moreover, not 
much is known about CCHF’s lung findings in specific 
and advanced imaging techniques, such as computed 
tomography (CT), and their clinical importance and ben-
efits in follow-up. In this study, we evaluated patients that 
were diagnosed with CCHF and whose thorax CT scans 
were taken due to pulmonary symptoms. We aimed to 
demonstrate the relationship between clinical follow-up 
findings and laboratory values among these patients.
Methods
The patients that were admitted to Tokat State Hospi-
tal Emergency Department and Infectious Diseases and 
Clinical Microbiology Department and diagnosed with 
CCHF between April 2010 and September 2015 were 
examined. Also Tokat State Hospital Infection Disease 
and Clinical Microbiology Department granted us access 
to all patients’ datas and then patients’ medical records 
were evaluated retrospectively. Patients who underwent 
thorax CT evaluation based on the clinical findings at 
the time of admission and/or during the hospital stay 
were included in the study. Ethical approval was obtained 
from ethics committee of Tokat Gaziosmanpaşa Uni-
versity. Patients’ laboratory test results, chest X-ray, and 
thorax CT findings for respiratory assessment along with 
demographic characteristics such as age, gender, occupa-
tion, place of residence, tick exposure, smoking history, 
clinical diseases, and medical history laboratory were 
evaluated.
Blood samples were taken from the patients at the time 
of admission for diagnostic purposes and were sent to 
Ankara Refik Saydam Hıfzısıhha Central Virology Labora-
tory. The diagnosis of CCHF was then made based on the 
enzyme-linked immunosorbent assay (ELISA) or by detec-
tion of viral genome by polymerase chain reaction (PCR).
Statistical analysis
Data was expressed as mean ± SD or frequency and per-
cent. Independent sample t test or one-way analysis of 
variance were used in order to compare the continuous 
normal data between groups. The Turkey HSD test was 
used for post hoc comparisons between the pair-wise 
groups. Furthermore, the Kaplan–Meier method was 
used for survival probability. A p value <0.05 was consid-
ered to be significant and analyses were performed using 
SPSS 19 (IBM SPSS Statistics 19, SPSS Inc., an IBM Co., 
Somers, NY).
Results
A total of 563 CCHF patients that were admitted to 
Tokat State Hospital Emergency Department and Infec-
tious Diseases and Clinical Microbiology Department 
between April 2010 and September 2015 were evaluated 
for this study. Forty patients that underwent thorax CT 
based on their indications were included in the study. 
Thirteen patients (37.5 %) were female with a mean age 
of 51.15 ±  15.91  years, while 27 patients (62.5  %) were 
male with a mean age of 55.22 ± 19.84 years. There was 
no significant difference between males and females in 
terms of mean age. Patients’ demographic characteristics 
are given in detail in Table 1.
The comparative evaluation of thorax CT find-
ings between the gender groups showed that the only 
Table 1 Demographic and clinical features of CCHF patients 
in the study
Variables Values n (% or ±SD)
Age <65 years 26 (65 %)
≥65 years 14 (35 %)
Gender Female (mean age 
51.15 year ± 15.91)
13 (32.5 %)
Male (mean age 
51.15 year ± 15.91)
27 (67.5 %)
Smoking habit Non-smoker 15 (37.5 %)
Smoking 24 (60 %)
Ex-smoker 1 (2.5 %)
Symptoms Fever 39 (97.5 %)
Fatigue 36 (90 %)
Myalgia 17 (42.5 %)
Vomiting 9 (22.5 %)
Enteritis 9 (22.5 %)
Abdominal pain 13 (32.5 %)
Inappetence 4 (10 %)
Eruptions 8 (20 %)
Bleeding 11 (27.5 %)
Cough 9 (22.5 %)
Somnolence 13 (32.5 %)
Headache 10 (25 %)
Dizziness 9 (22.5 %)
Hospitalization place Inpatient service unit 21 (52.5 %)
Critical care unit 5 (12.5 %)
Both 14 (35 %)
Mean hospitalization time 
(day)
In inpatient service unit 
(day)
10.17 (±8.18)
In critical care unit (day) 8.73 (±6.75)
Treatment Supportive treatment 35 (87.5 %)
Supportive and antiviral 
treatment
5 (12.5 %)
Survival Alive 26 (65 %)
Death 14 (35 %)
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significant increase was in pulmonary artery diameter 
(p  <  0.05). In addition, among the reported symptoms, 
only the presence of petechiae and ecchymotic rash were 
significantly different among gender groups (p  <  0.05). 
There were no other significant relationships between 
gender and patients’ clinical, radiological, and laboratory 
parameters.
Patients were divided into two groups based on their 
age, being composed of under and over the age of 65. 
Twenty-six patients (65 %) were over the age of 65 years. 
According to our results, symptoms of myalgia were 
more common in patients in the <65 age group and the 
difference between the age groups was statistically sig-
nificant. In addition, 10 of the 11 patients (38.5 %) with 
minor bleeding (such as epistaxis, menorrhagia, and 
mucosal bleeding) were in the >65 age group. These find-
ings were found to be statistically significant and no other 
significant associations were detected between age and 
other findings.
Laboratory evaluation included biochemical, hema-
tologic, coagulation, and inflammatory parameters. 
Furthermore, mean and standard deviation values of all 
parameters were calculated. The laboratory values of the 
patients are shown in detail in Table 2.
The patients’ radiological chest CT findings were 
evaluated. The radiological assessment showed a total 
of 13 thorax CT findings, with one patient having mul-
tiple findings. According to these results, the three most 
common thorax CT findings were parenchymal infiltra-
tion [32 patients (80  %)], pleural effusion [31 patients 
(77.5  %)], and alveolar infiltration [28 patients (70  %)]. 
Meanwhile, the least common CT findings were bron-
chiectasis [3 patients (7.5 %)] and mediastinal lymphade-
nopathy [2 patients (5 %)]. Moreover, we determined that 
the most frequently seen radiological findings such as 
parenchymal infiltration, alveolar infiltration, and pleural 
effusion often occurred bilaterally (Figs. 1, 2 and 3). The 
unilateral pathology was seen less frequently and most of 
these cases occurred in radiographic findings of the right 
lung. Patients’ thorax CT findings are summarized in 
detail in Tables 3 and 4.
In this study we also evaluated patients’ survival, factors 
affecting survival, and the association between survival 
and patients’ other clinical, laboratory, and radiological 
parameters. A total of 26 patients (65 %) survived, while 
14 patients (35  %) did not survive. We also determined 
that presence of symptoms such as rash, sleepiness, and 
dizziness at the time of admission was significantly asso-
ciated with survival (p < 0.05). Parenchymal and alveolar 
infiltration, pleural effusion, and atelectasis that were 
significantly associated with survival and were more fre-
quently seen in the non-survival group were observed 
bilaterally in thorax CT scans. Both the patients’ survival 
and the relationship between thorax CT findings are pre-
sented in detail in Table 5. Moreover, the patients’ mor-
tality rate was also calculated and found to be 35 %.
Patients that were diagnosed with CCHF based on their 
radiological findings underwent a chest X-ray (CXR). 
The presence of pathological findings on CXR and 
Table 2 The laboratoury findings of  CCHF patients in  the 
study
SD standard deviation
Parameters Mean SD± Normal range
Alkaline phosphatase (ALP) 178.72 156.07 35–270 U/L
Albumin 3.51 0.39 3.5–5 mg/dL
Alanine aminotransferase (ALT) 413.64 767.18 7–35 U/L
Aspartate aminotransferase 
(AST)
1330.07 2811.95 10–38 U/L
Blood uremia nitrogen (BUN) 35.53 33.27 8–23 mg/dL
Direct bilirubin 1.14 2.10 0.01–0.3 mg/dL
Gamma glutamyl transferase 
(GGT)
254.07 266.50 5–61 U/L
Creatine kinase (CK) 1303.55 1747.15 0–170 U/L
C-reactive protein (CRP) 76.95 82.60 0–5 mg/L
Calcium 8.13 0.78 8.8–10.6 mg/dL
Creatinine 1.69 1.58 0.6–1.09 mg/dL
Lactate dehydrogenase (LDH) 1798.62 2153.65 135–214 U/L
Total bilirubin 1.64 2.49 0.01–1.2 mg/dL
Uric acid 6.11 3.78 3.5–7.2 mg/dL
White blood cell 3.56 3.77 4.5–10 103/µL
Neutrophile 2.64 3.40 2–8.9 103/µL
Lymphocyte 0.67 0.48 1. 3–3.35 103/µL
Monocyte 0.25 0.27 0.25–0.85 103/µL
Red blood cell 4.67 0.86 4.5–5.9 106/mL
Red cell distribution width 
(RDW)
14.33 3.32 12.1–14.3 %
Hemoglobin 13.00 2.70 13.5–17.5 gr/dl
Haematocrit 38.01 7.44 41–53 %
Platelet 33.26 27.73 150–400 103/μL
Platelet distribution width 
(PDW)
22.80 5.63 10.1–16.1 %
Mean platelet volume (MPV) 11.36 2.39 9.1–11.9 fL
Partial thromboplastin time 
(%PTT)
79.55 29.00 70–120 %
Partial thromboplastin time 
(PTT)






67.43 28.09 23–35 s
D-dimer 6.92 4.59 0–0.5 mg/dL
Fibrinogen 284.03 111.10 202–430 mg/dL
Ferritin 16,860.40 19,272.16 20–400 µg/L
Procalcitonin 2.75 4.65 0–0.05 µg/L
Sedimentation 25.35 26.70 0–20 mm/h
Page 4 of 7Aktaş et al. SpringerPlus  (2016) 5:1823 
pleural effusion, parenchymal and alveolar infiltration, 
and bronchiectasis seen on thorax CT scans were sig-
nificantly associated. Other findings were only detected 
on thorax CT scans and not on CXR. The relationship 
between CXR and thorax CT findings are given in detail 
in Table 6.
Discussion
CCHF is a viral zoonotic disease. It is endemic in many 
geographic regions of the world and is seen at the end 
of spring as well as during the summer months and 
can cause life-threatening bleeding. There is still not 
much information regarding the etiopathogenesis, 
clinical follow-up, and treatment; however it is known 
that CCHF is transmitted through tick bites and that Nai-
rovirus is the main factor that causes intense systemic 
inflammatory response in the entire body. As a result of 
this inflammatory response, non-specific signs such as 
fever, fatigue, and myalgia occur in the acute phase. Dur-
ing the advanced stages of the disease, low platelets can 
cause serious spontaneous bleeding and even neurologi-
cal symptoms.
In our study, the male to female ratio was about 2–1 
(27/13), which was similar to other studies in the lit-
erature. In our country and region, mostly men work in 
occupations such as farming, animal husbandry, veteri-
nary medicine, and the military which require a frequent 
Fig. 1 Fourty years old female patient with the alveolar densities and 
ground glass opacities (alveolar hemorrhage) were seen in computer-
ized tomography (CT) scanning of the chest
Fig. 2 The same patient in Fig. 1 with bilateral pleural effusion is seen 
in CT scanning of the chest
Fig. 3 Twenty-six years old female patient with bilateral pleural effu-
sion and consolidation with air bronchograms at the right lower lobe 
are seen in CT scanning of the chest
Table 3 Thoracic CT findings of CCHF patients in the study




Alveolar infiltration 28 (70 %) 12 (30 %)
Parenchymal infiltration 32 (80 %) 8 (20 %)
Pleural effusion 31 (77.5 %) 9 (22.5 %)
Atelectasis 26 (65 %) 14 (35 %)
Small-airway involvement 13 (32.5 %) 27 (67.5 %)
Enlargement of pulmonary artery 27 (67.5 %) 13 (32.5 %)
Cardiomegaly 6 (15 %) 34 (85 %)
Pericardial effusion 5 (12.5 %) 35 (87.5 %)
Ground-glass opacity 23 (57.5 %) 17 (42.5 %)
Consolidation 11 (27.5 %) 29 (72.5 %)
Mediastinal/hilar lymphadenopathies 2 (5 %) 38 (95 %)
Chronic fibrotic changes 9 (22.5 %) 31 (77.5 %)
Bronchiectasis 3 (7.5 %) 37 (92.5 %)
Pulmonary nodule 8 (20 %) 32 (80 %)
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outdoor presence. Therefore, men are more likely to 
come into contact with ticks that are vectors for CCHF 
transmission.
CCHF is a blood borne and contagious disease. There-
fore, there are many studies in literature focusing on 
blood, other body fluids, and evaluating laboratory find-
ings. Some studies have reported that there is a strong 
relationship between survival and parameters such as 
d-dimer, fibrinogen, platelets, leukocytes, neutrophil 
count, and muscle and liver enzymes (Karti 2009; Ergönül 
2006; Watts et  al. 1988; Schwarz et  al. 1997). Similar to 
studies in literature, survival was significantly associated 
with parameters such as leukocytes, neutrophils, and 
platelet counts in the blood count test; ALT, AST, BUN, 
direct bilirubin, CK, creatinine, LDH, total bilirubin, uric 
acid in the biochemical tests; fibrinogen, d-dimer, ferri-
tin, PTT, and APTT in the coagulation test (p < 0.05).
The number of studies focusing on lung findings in 
CCHF is very limited. In all of these studies, lung evalua-
tions were performed based on the plain radiography and 
to the best of our knowledge, there are no other studies 
performed with thorax CT. In 2007 a  study from Rus-
sia by Sannikova et al. was the first study that evaluated 
Table 4 Locations of  the radiological findings in  CCHF 
patients with assessment of thoracic CT
Thorax CT findings Location n (%)
Alveolar infiltration Bilateral 19 (47.5 %)
Right 7 (17.5 %)
Left 2 (5 %)
None 12 (30 %)
Parenchymal infiltration Bilateral 20 (50 %)
Right 9 (22.5 %)
Left 3 (7.5 %)
None 8 (20 %)
Pleural effusion Bilateral 15 (37.5 %)
Right 14 (35 %)
Left 2 (5 %)
None 9 (22.5 %)
Atelectasis Bilateral 22 (55 %)
Right 4 (10 %)
None 14 (35 %)
Small-airway involvement Bilateral 9 (22.5 %)
Right 2 (5 %)
Left 2 (5 %)
None 27 (67.5 %)
Enlargement of pulmonary artery Bilateral 27 (67.5 %)
None 13 (32.5 %)
Ground-glass opacity Bilateral 17 (42.5 %)
Right 6 (15 %)
None 17 (42.5 %)
Consolidation Bilateral 8 (20 %)
Right 1 (2.5 %)
Left 2 (5 %)
None 29 (72.5 %)
Mediastinal/hilar lymphadenopathies Bilateral 2 (5 %)
None 38 (95 %)
Table 5 The comparison between survival and thoracic CT 
findings of CCHF patients
Statistically significant p values are in Italic





Atelectasis 14 (53.8) 12 (85.7) 0.044
Parenchymal infiltration 18 (69.2) 14 (100) 0.020
Alveolar infiltration 15 (57.7) 13 (92.9) 0.021
Cardiomegaly 3 (11.5) 3 (21.4) 0.403
Enlargement of pulmonary artery 17 (65.4) 10 (71.4) 0.697
Small-airway involvement 9 (34.6) 4 (28.6) 0.697
Pericardial effusion 2 (7.7) 3 (21.4) 0.210
Mediastinal/hilar lymphadenopathies 1 (3.8) 1 (7.1) 0.648
Pulmonary nodule 6 (23.1) 2 (14.3) 0.507
Ground-glass opacity 13 (50) 10 (71.4) 0.191
Consolidation 6 (23.1) 5 (35.7) 0.393
Chronic fibrotic changes 9 (34.6) 0 (0) 0.012
Bronchiectasis 2 (7.7) 1 (7.1) 0.950
Pleural effusion 17 (65.4) 14 (100) 0.012
Table 6 The comparison between the radiological findings 
of chest X-ray and thoracic CT in CCHF patients
Statistically significant p values are in Italic





Atelectasis 3 (50) 23 (67.6) 0.403
Parenchymal infiltration 2 (33.3) 30 (88.2) 0.002
Alveolar infiltration 1 (16.7) 27 (79.4) 0.002
Cardiomegaly 1 (16.7) 5 (14,7) 0.901
Enlargement of pulmo-
nary artery
3 (50) 24 (70.6) 0.321
Small-airway involve-
ment
0 (0) 13 (38.2) 0.065
Pericardial effusion 0 (0) 5 (14,7) 0.315
Mediastinal/hilar lym-
phadenopathies
0 (0) 2 (5.9) 0.542
Pulmonary nodule 1 (16.7) 7 (20.6) 0.825
Ground-glass opacity 3 (50) 20 (58.8) 0.687
Consolidation 0 (0) 11 (32.4) 0.102
Chronic fibrotic 
changes
1 (16.7) 8 (23.5) 0.711
Bronchiectasis 1 (16.7) 2 (5.9) 0.355
Pleural effusion 1 (16.7) 30 (88.2) <0.001
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lung findings in CCHF. In their study, lung findings of 
283 patients with acute respiratory distress syndrome 
(ARDS) were defined and it was noted that these symp-
toms could be seen in all periods, most notably in the 
hemorrhagic phase. In addition, they concluded that 
ARDS symptoms that may occur throughout the course 
of the disease are closely associated with systemic inflam-
mation and that this clinical condition may accompany 
hemorrhagic symptoms (Sannikova et al. 2007). In 2012, 
a Turkish study by Bilgin et al. evaluated lung findings of 
128 CCHF patients, retrospectively. The most frequently 
detected pulmonary symptoms were cough, sputum, and 
chest pain. In addition, they reported that there was no 
significant difference between patients with and without 
radiological findings in terms of survival. In the major-
ity of patients (65.5  %) that had radiological findings, 
these findings were bilateral. However, the study only 
evaluated direct radiography findings and abnormal 
findings that were detected included infiltration, hilar 
pathology, interstitial pathology, pleural thickening, and 
pleural effusion (Bilgin et  al. 2014). Another study that 
evaluated lung findings of CCHF was done by Doğan 
et  al. in 2011. The study assessed demographic, clini-
cal, and radiological parameters as well as pulmonary 
symptoms of 108 patients diagnosed with CCHF. Similar 
to the aforementioned studies, the radiological assess-
ments were done based on the direct radiography find-
ings. Abnormal findings in direct radiography were not 
detected in 66.7  % of patients. On the other hand, the 
majority of the radiological findings detected in direct 
radiography were unilateral (Dogan et al. 2011). In litera-
ture, there are single case reports for both pediatric and 
adult cases that used direct radiography and thorax CT 
to evaluate lung findings. Pleural effusion was found in 
almost all case reports and is the most frequent as well 
as the most well defined radiological finding in CCHF 
patients in literature. Although, the precise pathophysi-
ological mechanisms of pleural effusion are not known, 
it is widely thought to develop as a result of widespread 
systemic inflammation. However, it is recommended that 
differential diagnosis of hemothorax should be included. 
It is suggested that the pleural effusion that develops in 
the course of the disease is not associated with hemotho-
rax (Schnittler and Feldmann 2003; Feldman et al. 2003; 
Tanir et al. 2009). In Doğancı et al.’s case report from Tur-
key, a young adult diagnosed with CCHF had an alveo-
lar hemorrhage at the time of admission to the hospital, 
which regressed dramatically on day 5 after ribavirin and 
supportive treatment (Doganci et al. 2008). Although the 
authors suggested that excessive inflammatory response 
was the reason, it remains unclear whether thrombocy-
topenia and/or vascular injury might have been the main 
factors in the pathophysiology.
There are 4 stages of clinical follow-up in CCHF: incu-
bation phase, pre-hemorrhagic phase, hemorrhagic 
phase, and convalescent phase (Ergönül 2008; Bakir et al. 
2005). In our study, the patients underwent thorax CT for 
further diagnosis due to the emergence of new findings in 
the pre-hemorrhagic and hemorrhagic phase at the time 
of admission and/or during the clinical follow-up. Radio-
logical findings suspected to be pulmonary pathologies of 
CCHF were seen in all patients. Inadequacies in the dif-
ferential diagnosis and further investigations may occur, 
especially in the pre-hemorrhagic phase because patients 
come in with symptoms similar to the common cold. In 
particular, the most frequently seen thorax CT findings, 
such as parenchymal infiltration, alveolar infiltration, 
pleural effusion, and atelectasis, are significantly related 
with survival which in turn, emphasizes the importance 
of these parameters in clinical follow-up. In addition, if 
these findings develop in advanced stages of the dis-
ease, such as hemorrhagic and convalescent phases, they 
might serve as indicators of poor prognosis.
The presence of fibrotic changes in thorax CT find-
ings was also found to be significantly related to survival. 
Interestingly, all nine patients that developed fibrosis sur-
vived. This can be explained by insufficient inflammatory 
response in patients with fibrotic changes. However, this 
view is based exclusively on our clinical data and further 
studies at the cellular and molecular level are required.
In our study, we also compared direct radiography 
and thorax CT in terms of their success in revealing 
radiologic findings. In all previous studies only direct 
radiography was used for the assessment of the lung 
and none of them felt the need to use thorax CT for 
advanced diagnosis. Therefore, we wanted to evaluate 
the adequacy of direct radiography in the assessment 
of the lung findings in patients with CCHF. The direct 
radiography can detect the radiological findings most 
frequently seen in thorax CT such as pleural effusion, 
alveolar, and parenchymal infiltration. The correlation 
between direct radiography and thorax CT in terms of 
detection of radiologically similar findings was statisti-
cally significant (p < 0.05). This suggests that it is more 
appropriate to use simple, cheap, and easily accessible 
direct lung radiography in the initial diagnosis of CCHF, 
however in cases with additional pathological findings, 
differential diagnosis or the absence of clinical improve-
ment thorax CT should be used for further examination 
in clinical follow-up. Therefore, CXR should be con-
sidered especially in patients in the hemorrhagic phase 
for detection of pulmonary pathologies such as alveo-
lar hemorrhage and pleural effusion, while thorax CT 
should be considered for further evaluation. Moreover, 
it should be deliberated that the pre-hemorrhagic phase, 
in which the symptoms emerge, will be followed by the 
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hemorrhagic phase when the clinical manifestations 
could occur, and thus radiological assessment of the 
lungs should be carried out after the admission to the 
hospital. This radiological evaluation will be very useful 
in terms of calculating both the survival and the clinical 
course of the disease.
In conclusion, there is still not enough information 
regarding this life-threatening disease that is endemic in 
many geographic regions of the world. Furthermore, the 
number of deaths due to CCHF is increasing every year. 
In CCHF, the intense inflammatory response affects 
all systems, including the circulation and hematologi-
cal system and clinical implications of the liver as well. 
However, information regarding effects on the respira-
tory system is very limited. In particular, the informa-
tion regarding the radiologic evaluations and findings for 
this disease is insufficient. In cases with life-threatening 
clinical conditions it is important to evaluate radiologi-
cal findings in the respiratory system by using direct 
radiography and by using thorax CT when differential 
and advance diagnosis is needed. We also would like to 
emphasize that both direct radiography and thorax CT 
are highly successful in detecting frequently encountered 
radiological findings such as pleural effusion, alveolar 
hemorrhage, and parenchymal infiltration that indicate 
pulmonary involvement and have a negative effect on 
survival and therefore should be used in the evaluation 
of patients with CCHF.
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